| Literature DB >> 27536596 |
Byung-Woo Min1, Kwang-Soon Song1, Ki-Cheor Bae1, Chul-Hyun Cho1, Eun-Suck Son1, Kyung-Jae Lee1.
Abstract
Osteoporosis is a metabolic disease that is increasing in prevalence as people live longer. Because the orthopedic surgeon is frequently the first and often the only physician to manage patients with osteoporotic hip fractures, every effort should be made to prevent future fractures. A multidisciplinary approach is essential in treatment of osteoporotic fractures. Basic treatment includes calcium and vitamin D supplementation, fall prevention, hip protection, and balance and exercise programs. Currently available pharmacologic agents are divided into antiresorptive and anabolic groups. Antiresorptive agents such as bisphosphonates limit bone resorption through inhibition of osteoclastic activity. Anabolic agents such as parathyroid hormone promote bone formation.Entities:
Keywords: Hip fractures; Medication; Osteoporosis
Year: 2015 PMID: 27536596 PMCID: PMC4972623 DOI: 10.5371/hp.2015.27.1.9
Source DB: PubMed Journal: Hip Pelvis ISSN: 2287-3260